Business and Finance

Healthcare tech company acquires Medical Marketing Economics, a provider of value-based strategy support

Wholesaler's 3PL arm to provide logistics and distribution support to potential emergency use drug for patients with critical Covid with respiratory failure

CAGR growth through 2026 will be 6.4% per year

Deal for CHC Health adds depth, scale and expanded clinical expertise in health outcomes pursuits

Venture anticipated to more than double single-use bioreactor mammalian cell-culture capacity on site

Acquisition addresses the need for meeting healthcare sector’s patient support demand

Deal allows for bicoastal expansion of pharmaceutical services

How the development of more quantitative and qualitative data around the patient can drive better-informed care decisions—and help avoid potential overstock scenarios that can deplete earnings

Plan aims to offset costs associated with proposed social and health initiatives

Among focal points, New Jersey location will support clinical research, pharmacovigilance

WuXi STA will take reigns of the operations, as CDMO expands

State and regional economic-development authorities compete fiercely for siting new pharma enterprises, and holding onto the ones they have. But pharma’s stupendous growth in investment is giving all regions a boost

Sector is expected to be driven by a rise in drug development and regulatory approvals for advanced therapies

Acquisition of US partner establishes Sanofi's plan to advance messenger RNA technology for vaccines, therapeutics

Guidance supports cross-industry collaboration for improved interoperability

Private equity companies see the sector as having a valuable ROI, according to study

Pharmacy discount card company and e-commerce specialist team up on new Rx-med procedures channel

Deal for antibody developer expected to be largest ever for scientific instrument maker

Acquisition is centered on market access and patient advocacy

Report notes that companies particularly look to vendor support for technologies such as 5G, IoT, and blockchain

Plans a multi-phase, $100 million expansion, adding biologics drug substance manufacturing capabilities

Deal allows CDMO to quickly expand its drug delivery technologies in the US

Aims to grow its digital clinical trial offerings internationally

CDMO looks to strengthen its presence in Belgium, Sweden and the Netherlands

EmerGENE to support biotechs in clinical-to-commercialization process, including distribution and logistics